Restoring adult cell function provides an exciting approach for rejuvenating aging human organs. The concept of Dystrogen’s anti-aging treatment is based again on the delivery of multi chimeric cells created from the umbilical blood cord cells (UBC) or bone marrow derived mesenchymal stem cells (MSC) or combination of both, as the anti-aging, anti-inflammatory, and immunomodulatory therapy.
With increasing life expectancy of the aging population, chimeric cells introduce a new therapeutic approach to treat age-associated frailty and disability. Different sources of stem cells are tested to confirm safety, efficacy, and regenerative potential after treatment.
In this context, our novel MCC therapy based on the UBC and MSC can be tailored based on the individual patient's needs and as such represents unique and promising anti-aging potential.